InsidersTradesSigma
Discover the detailed record of transactions filed by LEA LEIV, Chief Financial Officer. Insider active across 1 companies, notably Corvus Pharmaceuticals, Inc.. Aggregated, 1 disclosures have been recorded. Total volume traded: €49k. The latest transaction was disclosed on 16 March 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
Leiv Lea serves as Chief Financial Officer at Corvus Pharmaceuticals, Inc. He is responsible for the financial management of the company, including financial planning, risk management, and financial reporting. With a strong background in the pharmaceutical sector, Leiv Lea is committed to ensuring the financial health of Corvus Pharmaceuticals and supporting its strategic growth. His role is essential in ensuring compliance with financial regulations.